45 results match your criteria: "Manchester Centre for Clinical Neuroscience[Affiliation]"
Eur J Hum Genet
November 2024
Division of Neuroscience and Neuroscience Institute, The University of Sheffield, Sheffield, UK.
Biomedicines
September 2024
Faculty of Medicine, University of Medicine and Pharmacy "Carol Davila", 020022 Bucharest, Romania.
Background: Rheumatoid arthritis (RA) patients are at heightened risk of Coronavirus Disease-19 (COVID-19) complications due to immune dysregulation, chronic inflammation, and treatment with immunosuppressive therapies. This study aims to characterize the clinical and laboratory parameters of RA patients diagnosed with COVID-19, identify predictive risk factors for severe forms of this infection for RA patients, and determine if any RA immunosuppressive therapy is associated with worse COVID-19 outcomes.
Methods: A retrospective observational case-control study included 86 cases (43 diagnosed with RA and 43 cases without any inflammatory or autoimmune disease) that suffered from SARS-CoV-2 in two Romanian hospitals between March 2020 and February 2024.
Curr Oncol
April 2024
Plastic Surgery Department, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
In recent years, there has been an observed increase in the frequency of cutaneous carcinoma, which correlates with sun exposure. This study aims to explore the variances of tumor characteristics and immune response markers among patients diagnosed with cutaneous squamous-cell carcinoma (SCC) and basosquamous-cell carcinoma (BSC) with varying levels of sun exposure. The objective is to elucidate the potential influence of sun exposure on tumor progression and immune response in these types of carcinomas.
View Article and Find Full Text PDFNeuromuscul Disord
May 2024
Manchester Centre for Clinical Neuroscience, Northern Care Alliance NHS Foundation Trust, Salford Royal, Stott Lane, Salford, M6 8HD, UK; The University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, Manchester, M13 9WU, UK.
Nat Rev Rheumatol
May 2024
Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Pract Neurol
July 2024
Neurology Department, Manchester Centre for Clinical Neuroscience, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Nat Rev Rheumatol
November 2023
Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases that affect the skeletal muscles and can also involve the skin, joints, lungs and heart. The epidemiology of IIM is obscured by changing classification criteria and the inherent shortcomings of case identification using healthcare record diagnostic coding. The incidence of IIM is estimated to range from 0.
View Article and Find Full Text PDFRheumatology (Oxford)
August 2024
Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK.
Objectives: To compare clinical characteristics, including the frequency of cutaneous, extramuscular manifestations and malignancy, between adults with anti-synthetase syndrome (ASyS) and DM.
Methods: Using data regarding adults from the MYONET registry, a cohort of DM patients with anti-Mi2/-TIF1γ/-NXP2/-SAE/-MDA5 autoantibodies, and a cohort of ASyS patients with anti-tRNA synthetase autoantibodies (anti-Jo1/-PL7/-PL12/-OJ/-EJ/-Zo/-KS) were identified. Patients with DM sine dermatitis or with discordant dual autoantibody specificities were excluded.
J Neurol Neurosurg Psychiatry
September 2023
Barts Health NHS Trust, London, UK
J Neurosurg
October 2023
1Department of Neurosurgery, Manchester Centre for Clinical Neuroscience, Manchester.
Objective: Preoperative differentiation of facial nerve schwannoma (FNS) from vestibular schwannoma (VS) can be challenging, and failure to differentiate between these two pathologies can result in potentially avoidable facial nerve injury. This study presents the combined experience of two high-volume centers in the management of intraoperatively diagnosed FNSs. The authors highlight clinical and imaging features that can distinguish FNS from VS and provide an algorithm to help manage intraoperatively diagnosed FNS.
View Article and Find Full Text PDFFront Neurol
May 2022
John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Spinal Muscular Atrophy (SMA) is characterized by muscle atrophy and weakness and has an incidence of 1:11. 000 live births which projects an estimated population in the UK of 650-1,300 affected patients. Standards of Care (SoC) were updated in 2017 and they have been widely adopted as a reference for implementation of care in SMA across the globe.
View Article and Find Full Text PDFPract Neurol
June 2022
Neurology, Manchester Centre for Clinical Neuroscience, Greater Manchester, UK.
Pract Neurol
April 2022
Neurology, Manchester Centre for Clinical Neuroscience, Greater Manchester, UK.
Clin Exp Rheumatol
February 2022
National Institute for Health Research, Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, The University of Manchester; Department of Rheumatology, Salford Royal Hospital, Manchester Academic Health Science Centre, Salford; and Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester, UK.
Objectives: The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of immune-mediated systemic disorders that commonly target skeletal muscles. The aim of our review is to remind clinicians to be vigilant of common mimickers, and what red flags to look for to avoid misdiagnosis.
Methods: We reviewed the clinical documentation and investigation results of illustrative real-life case examples of significant IIM mimickers with valuable learning points.
Pract Neurol
February 2022
Neurology, Manchester Centre for Clinical Neuroscience, Greater Manchester, UK.
Pract Neurol
December 2021
Neurology, Manchester Centre for Clinical Neuroscience, Greater Manchester, UK.
Pract Neurol
October 2021
Neurology, Manchester Centre for Clinical Neuroscience, Greater Manchester, UK.
J Neurol Neurosurg Psychiatry
October 2021
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
Objectives: We aimed to define the clinical and serological characteristics of pan-neurofascin antibody-positive patients.
Methods: We tested serum from patients with suspected immune-mediated neuropathies for antibodies directed against nodal/paranodal protein antigens using a live cell-based assay and solid-phase platform. The clinical and serological characteristics of antibody-positive and seronegative patients were then compared.
Rheumatology (Oxford)
April 2022
Manchester Centre for Clinical Neuroscience, Salford Royal NHS Foundation Trust, Salford.
Objectives: Diagnosing the idiopathic inflammatory myopathies (IIMs) can be challenging as several conditions, including genetic myopathies such as limb girdle muscular dystrophy type R12 (LGMD 2 l, anoctaminopathy) mimic the presentation. Here we describe learning points identified from review of four patients with LGMD 2 l who were initially incorrectly diagnosed with IIM. Our aim is to provide clinicians working in adult rheumatology services with a toolkit to help identify non-inflammatory presentations of myopathy.
View Article and Find Full Text PDFClin Rheumatol
December 2021
National Institute for Health Research Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
This study aims to describe the patient perspective on glucocorticoid (GC) treatment and adverse effects (AEs) in idiopathic inflammatory myopathy (IIM). An online survey was distributed to patients with adult-onset IIM using the Myositis UK page on Healthunlocked.com, an online social network for health.
View Article and Find Full Text PDFPract Neurol
June 2021
Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, UK.
Alzheimers Dement
July 2021
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Introduction: The aged brain frequently exhibits multiple pathologies, rather than a single hallmark pathology (pure pathology [PurP]), ranging from low/intermediate levels of additional pathology (LowP) to mixed severe pathology (mixed SevP). We investigated the frequency of PurP, LowP, and mixed SevP, and the impact of additional LowP on cognition.
Methods: Data came from 670 cases from the Brains for Dementia research program.
Rheumatology (Oxford)
July 2021
National Institute for Health Research Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Objective: The current classification criteria for idiopathic inflammatory myopathy (IIM) retain PM as a major disease subgroup. However, evolution in the understanding of IIM has suggested that many of these patients could be better described as having an alternative diagnosis. In the present study, we apply the latest understanding of IIM subtyping to retrospectively review PM diagnoses in a large cohort of IIM patients.
View Article and Find Full Text PDFBrain
March 2021
Department of Neuromuscular Diseases, University College London, London, UK.
Pract Neurol
December 2020
Neurology, Manchester Centre for Clinical Neuroscience, Greater Manchester, UK.